Table 2 Plasma somatostatin (SOM) and pituitary adenylate cyclase activating polypeptide-38 (PACAP-38) levels determined by radioimmunoassay in healthy controls and Raynaud patients with or without symptoms. Data represent the means±SEM of each group
Healthy | Raynaud without symptoms | Raynaud with symptoms | |
|---|---|---|---|
Somatostatin (fmol/ml) | 4.9 ± 0.3 | 4.9 ± 0.4 | 5.6 ± 0.5 |
PACAP-38 (fmol/ml) | 15.8 ± 1.6 | 15.2 ± 1.5 | 13.1 ± 1.4 |